The Art of Fermentation by Sandor Katz

The Art of Fermentation by Sandor Katz was published two weeks and I got a copy from the publisher. It has a few conceptual chapters (“fermentation as a coevolutionary force”, health benefits, small business) but most of it is DIY, how to ferment X, Y, and Z. Unlike a set of recipes, he includes background with each food so the result is a cross between an encyclopedia and a cookbook. There are also several pages of color photographs, cute marginal drawings, and excellent lists of references and sources. It covers lots of stuff I rarely see. For example, there is one page on fermenting eggs. When I’m in China, I eat lots of fermented eggs. The book doesn’t mention the controversy in China about heavy metals in the fermented eggs.

The author’s enthusiasm is contagious and I’m sure the book will encourage me to ferment more stuff. Nowadays I just make yogurt, kefir, and kombucha — not even sauerkraut. I once got a book called something like The Book of Yogurt that consisted of 30 different yogurt recipes — which differed from each other by only about 5%. Page after page the same with only minor differences. Talk about cut and paste! I got rid of it (“this is useless!”) but now I wish I had saved it because it was so funny.

Which is only to say that food writing is either incredibly difficult or incredibly awful. I used to subscribe to Saveur. Some of their recipes were very good. The writing was awful, however — like something from a tourist guide. Please, don’t tell me how beautiful the country, how friendly the cook, or how tasty the food! Katz does better than that, especially when he is describing what he has actually done. But about half of the book reminds me of my first piece of extended writing — a “state report” about Maine that I did when I was in fifth grade. I went to several encyclopedias and copied the interesting stuff. Katz has gone to quite a few books and copied the interesting stuff.

In at least one case, he has copied too much. I have made yogurt hundreds of times. Only in the beginning did I do something like what practically everyone in America, including Katz, advocates: heat the milk up, let it cool, put in the culture. Now I just take the milk from the refrigerator, put in a tiny amount of culture, surround the milk with hot water (using a Chinese yogurt-making machine that keeps the water warm), and wait. So much easier. The final product is better (smoother, thicker) than the old hard way, especially when I learned that tiny amounts of culture work better than large amounts. “In my experience, cultures from commercial yogurts never maintain their viability beyond a few generations,” Katz writes. My experience is different: I’ve never had a problem using them.

In contrast to Harold McGee’s On Food and Cooking, The Art of Fermentation is more personal, more hands-on, and less scientific, all of which are improvements, in my opinion. It is also more opinionated, which since the opinions are commonplace, is bad. “I too love the beer they are usually thinking of . . . However I define beer more broadly than the famous 1516 Bavarian beer purity law . . . I define beer as a fermented alcoholic beverage in which . . . ” At another point, to my surprise, he mentions Jane Jacobs and her theory that agriculture began in cities. “If Jacobs’s theory is correct, then fermentation practices must also have had urban roots,” writes Katz. This is not interesting. The small business chapter is interesting whenever Katz is telling the story of a small business and uninteresting the rest of the time (“Consistency is not necessarily important to the home experimentalist”).

Oh well. I am glad to have a book that will encourage me to ferment more stuff and from which I can learn a lot about fermentation. The book is obviously a labor of love and there are not many of those.

Effect of Niacin on Restless Legs Syndrome: The Importance of Dosage

K. Thomas Packard, who works in the healthcare industry, recently studied the effect of niacin on his Restless Legs Syndrome. He had read how a megadose helped Dennis Mangan’s mother. He gave a talk about his results and posted at Genomera.

The niacin didn’t help him. However, the highest dose he tried was 500 mg/day. Mangan’s mom, who surely weighs less than Packard, took 1000 mg/day. He doesn’t explain why he thought a much lower dose would work. Perhaps he weighs twice as much as Mangan’s mom, so 500 mg/day, in terms of body weight, may have been only 25% of the dose that worked for her. It’s too bad he went to all that trouble and used a maximum dose that could easily have been too low.

Part of the study “hypothesis” (= idea to be tested?) was

The “medium” dose may generally be more effective, than both the “low” and “high” doses, in eliminating symptoms of RLS and avoiding side effects of niacin.

Why this might be true isn’t explained.

After Week 3, Packard wrote “The niacin was not working, so I abandoned the experiment on Wednesday. I went back to my original medication and am doing OK.” He says nothing about side effects.

Packard later found that his ferritin was low, apparently a side effect of this study. If his RLS persists after he improves his ferritin level, I hope he tries niacin again at better dosages.

No Mention of Fermented Foods in Article about Importance of Bacteria

A new article in the New York Times by Carl Zimmer is about the importance of the bacteria inside of us. Several studies are described. Then it comes to the practical use of the knowledge. Here’s what we can do to improve our inner bacterial ecology:

To ward off dangerous skin pathogens like Staphylococcus aureus, for instance, Dr. Segre envisions applying a cream infused with nutrients [Treatment 1] for harmless skin bacteria to feed on. . . . Adding the bacteria directly may also help. Unfortunately, the science of so-called probiotics [Treatment 2] lags far behind their growth in sales. In 2011, people bought $28 billion of probiotic foods and supplements. . . A growing number of doctors are treating C. difficile with fecal transplants [Treatment 3]: Stool from a healthy donor is delivered like a suppository to an infected patient. The idea is that the good bacteria in the stool establish themselves in the gut and begin to compete with C. difficile. This year, researchers at the University of Alberta reviewed 124 fecal transplants and concluded that the procedure is safe and effective.

No mention of fermented foods. The obvious difference between fermented foods and Treatments 1-3, besides pleasure (fermented foods more pleasurable), is that Treatments 1-3 can be sold for high prices. Fermented foods cannot. (Except wine.) The omission is curious. Just because the people that Zimmer interviews have tunnel vision doesn’t mean that Zimmer must.

 

 

The Difficulty of Finding a Good Experiment to Do

My self-experimentation began because of one tiny thing — an article I noticed in the Brown University Science Library about teaching mathematics to college students. “The best way to learn is to do,” it started. Which made sense. To learn how to do experiments — one of my goals as a graduate student — I started doing self-experiments. Let’s imagine I had never seen that article, which is entirely possible. In this parallel universe, I become a psychology professor and then one day notice that someone else has done the personal science I have actually done. Has written “ Self-experimentation as a source of new ideas,” The Shangri-La Diet, and so on, including the experiments I’ve described on this blog. How would I react?

Many things about it would not impress me. You devised an arithmetic test to measure your brain function — so what? You measured yourself for a long time — big deal. You did an experiment — yawn. I might be slightly impressed by the experimental designs, which are simple and effective. Most experimental psychology uses more complex designs. What would baffle me would be the discovery of safe powerful beneficial treatments. How did this guy find these treatments? For example, the first experiment in “Self-experimentation as a source of new ideas” is about the effect of breakfast on early awakening. Eliminating breakfast reduced the fraction of days with early awakening from about 50% to 10%. Not eating breakfast is easy and perfectly safe. I don’t know of anything like this in all sleep research.

To a psychology professor, doing an experiment on one’s sleep is nothing. Finding something naturalistic (= not a drug) and sustainable that caused a big improvement, however, would be . . . unprecedented? Seemingly impossible? Psychology professors study everyday topics of great interest, such as memory and problem-solving and happiness, quite often. They would love to find easy safe sustainable non-drug ways of improving these things by large amounts. But I can’t think of a single example.

I thought about how hard it is to find big beneficial experimental effects (it’s easy to make things worse) when I read this post by the economist Yanis Varoufakis. He is excited about working for an online game company (Valve) because the nature of their game will allow experimental study of economics.

Econometrics is a travesty! . . . Econometrics purports to test economic theories by statistical means. And yet what it ends up testing is whether some ‘reduced form’, an equation (or system of equations), that is consistent with one’s theory, is also consistent with the data. The problem of course is that the ‘reduced form’ under test can be shown to be consistent with an infinity of competing theories. Thus, econometrics can only pretend to discriminate between mutually contradictory theories. All it does is to discover empirical regularities lacking any causal meaning. [Why is he sure they lack any causal meaning? — Seth]. . . The reason for this unavoidable failure? None other than our inability to run experiments on a macroeconomy such as rewinding time to, say, 1932, in order to see whether the US would have rebounded without the New Deal (or to 2009 to see what would have happened to the US economy without Ben Bernanke’s Quantitative Easing). Even at the level of the microeconomy, keeping faith with the ceteris paribus assumption (i.e. keeping all other things equal in order to measure, e.g., the relationship between the price of and the demand for milk) is impossible (as opposed to just hard).

In sharp contrast to our incapacity to perform truly scientific tests in ‘normal’ economic settings, Valve’s digital economies are a marvelous test-bed for meaningful experimentation. . . . We can change the economy’s underlying values, rules and settings, and then sit back to observe how the community responds, how relative prices change, the new behavioural patterns that evolve. An economist’s paradise indeed…

I find this baffling. It’s like thinking: Now I can write. Soon I will be writing stuff that the world wants to read! Okay, now he can do experiments. Good. After a few of them, I suppose, he will learn what every experimental scientist knows and confronts every working day: it is incredibly hard to do interesting experiments. The “sharp contrast” between the new setting and the old one has yet to be demonstrated.

Okay, how did I find a bunch of big beneficial safe sustainable effects? I am now finishing a paper in which I try to answer this question. To be brief: 1. As I’ve said, I believe that the distribution of surprise/observation follows a power-law-like distribution. Almost all observations, very little surprise, a tiny fraction of observations, great surprise. Which is pretty obvious. 2. The “slope” (parameter) of the distribution depends on subject-matter knowledge (more knowledge = more favorable slope, i.e., “chance favors the prepared mind”), scientific skill (more skill = more favorable slope), and novelty (more novelty = more favorable slope). I was in good shape on all three. For example, when I studied sleep, I knew a lot about sleep. Novelty is enormously important. In my personal science I could easily study treatments (e.g., not eating breakfast) and dimensions (e.g., how rested I felt when I awoke) that had rarely if ever been studied before. I could do this again and again, keeping novelty high and thus keeping the slope very favorable. (Varoufakis will get a burst of novelty when he begins experimentation (the situation is new) but forced to use that situation for all his experiments the novelty will run down, making the slope of the distribution less favorable.) 3. My cost/observation was very low and the benefit/observation remarkably high (I was improving my own health). So I was very motivated to make observations. My answer in the paper is a little more complicated but that’s most of it.

Who Watches the Watchdogs? The Myths of Journalism

In a great essay, Edward Jay Epstein points out, at least by implication, that the Pulitzer Prize committee is not terribly interested in the truth of things:

A sustaining myth of journalism holds that every great government scandal is revealed through the work of enterprising reporters who by one means or another pierce the official veil of secrecy. . . This view of journalistic revelation is propagated by the press even in cases where journalists have had palpably little to do with the discovery of corruption. Pulitzer Prizes were thus awarded this year to the Wall Street journal for “revealing” the scandal which forced Vice President Agnew to resign and to the Washington Star/News for “revealing” the campaign contribution that led to the indictments of former cabinet officers Maurice Starts and John N. Mitchell, although reporters at neither newspaper in actual fact had anything to do with uncovering the scandals. . . . Yet to perpetuate the myth that the members of the press were the prime movers in such great events as the conviction of a Vice President and the indictment of two former cabinet officers, the Pulitzer Prize committee simply chose the news stories nearest to these events and awarded them its honors.

The Nobel Prize in Biology committee operates the same way, except with the disadvantage that there is not one important (= useful in a big way) biology discovery per year. There are far fewer than that. So almost every year the Nobel Prize in Biology goes to discoveries with little practical importance that are described as having great practical importance. The profession (in this case, biology) is credited with much more power than it actually has.

Why does this happen? One possible reason is that no one points it out. (Epstein’s essay, still relevant today, was published in 1974.) When a powerful journalistic institution does bad things, it is incredibly dangerous (to your career) to point this out. This is why the Murdoch scandal is so big — it went on so long. Spy magazine had a column called Review of Reviewers. It was hilarious because the misdeeds were great. Unlike almost anything else in Spy, the author was anonymous. Brilliant writing that the author did not take credit for because it was dangerous to criticize the watchdogs. Likewise, hardly anyone except Epstein criticizes the prize committees (who resemble watchdogs) so they can be profoundly inaccurate.

 

Double Interview on the Benefits of Probiotics

This curious 2006 article has an interview with one researcher in one column and an interview with another researcher in another column. Their results differed.

Pro probiotic. “Children with [infectious acute diarrhea] who took Lactobacillus [various strains and species, in nutritional supplement form, not in yogurt form] had a shorter duration of diarrhea (on average 0.7 days shorter) than those who took placebo. Also, they had fewer episodes of diarrhea, i.e. fewer stools, on the second day of treatment than those in the placebo group. Interestingly, the children who took higher doses of Lactobacillus had shorter duration of diarrhea, and it seems that a daily dose of at least 10 billion viable bacteria is necessary to have a beneficial effect.”

Anti probiotic. “I published a big study looking at Lactobacillus GG in kids with Crohn’s disease who were already doing fairly well on medication. We put them on the probiotic or a placebo for two years. We followed them for two years and looked for whether the probiotic group had a lower rate of relapse and whether there were any differences between the two groups. We didn’t find any differences.”

Assorted Links

  • New study shows that a Yakult probiotic drink helps people with lactose intolerance and the benefits persist 3 months after one month of drinking it. Yakult is common in Chinese and Japanese supermarkets but rare in American ones. Until I read this article, I didn’t realize that people drink it because of lactose intolerance, which is much more common in Asia than America. Via Cooling Inflammation.
  • news from the Human Microbiome Project. “To the scientists’ surprise, they also found genetic signatures of disease-causing bacteria lurking in everyone’s microbiome. But instead of making people ill, or even infectious, these disease-causing microbes simply live peacefully among their neighbors.” You may recall that a Nobel Prize was given for the discovery that ulcers are caused by a certain species of bacteria. However, almost everyone with the “disease-causing” bacteria does not get ulcers. Apparently the “surprise[d]” scientists studying the human microbiome did not know that. If it were better known that you don’t need to kill bacteria to make them harmless, antibiotic usage would be less attractive.
  • Air pollution epidemiologist fired from UCLA after his research contradicts claims about the danger of air pollution.
  • How to conduct a personal experiment: biphasic sleeping

Thanks to Melissa McEwen, Peter Spero, Tim Beneke, Dave Lull and Bryan Castañeda.

MIT Professor Reenacts the Movie Groundhog Day

A friend of mine went to college at MIT. “One of my professors repeated himself,” she said. “Every lecture was the same.”

The class was introductory physics. “You mean he gave the same lecture year after year?” I said.

“No. Every lecture.” Hard to believe, but yes, every lecture was the same. The professor was replaced in the middle of the term.

How Useful is Personal Genomics? A Case Study

How much can you help yourself by getting your genome sequenced? A lot, a little, not at all? Scenario 1 (big help): You discover you have a greatly elevated risk of Disease X. You do various things to reduce that risk that actually reduce it. Scenario 2: (a little help): You discover you have a greatly elevated risk of Rare Disease X. You do various things to reduce that risk but they don’t help. At least, when Disease X starts, you will be less upset. Scenario 3 (no help): You discover that you have a greatly elevated risk for a common easily-noticed disease (such as obesity). You already watched your weight, this changes nothing. Scenario 4 (harm): You discover that you have a greatly elevated risk of Scary Disease X (e.g., bipolar disorder). It is depressing news. Later studies show that the gene/disease association was a mistake. (Many gene/disease associations have failed to replicate.)

A recent Wired article tries to answer this question for one person: Raymond McCauley, a bioinformatics scientist who had his genome sequenced four years ago and learned he was “four or five times more likely than most people to develop age-related macular degeneration (AMD)”. The article says “of all the ailments described in the 23andme profile, AMD has one of the strongest genetic associations”. If I found this in my genetic profile, I would want to know the confidence interval of the increased risk. Is it a factor of 4.5 plus or minus 1? Or 4.5 plus or minus 8? This isn’t easy to figure out. In addition to the question of variability, there can easily be bias (= estimate is too high). Let’s say I do 100 gene/disease association studies. Then I scan these studies to pick the one with the strongest gene/disease association. It should be obvious that this particular association is likely to be too high and, depending on the details, could plausibly be pure chance (i.e., true association is zero). I have been unable to find out how replicable the gene/AMD association is. According to Wikipedia, “the lifetime risk of developing late-stage macular degeneration is 50% for people that have a relative with macular degeneration, versus 12% for people that do not have relatives with macular degeneration.” (Until it was eliminated via better diet, pellagra also ran in families.) The Wired article does not say whether any of McCauley’s relatives have/had AMD — a huge omission, given the uncertainty of gene/disease associations.

It wasn’t obvious what McCauley should do, according to the article:

McCauley read that there were a few preventative measures he could take to reduce the chances of AMD one day rendering him blind: don’t smoke and avoid ultraviolet light, for instance. Also, it seemed, he could try taking a special combination of vitamins, including B12 and lutein. But when he consulted the research, he could find little evidence to support the effectiveness of the regime, based on his genotype.

The article says nothing about quitting smoking but he does wear glasses that reduce ultraviolet light and takes certain vitamins. It is very hard for him to determine whether they help.

Here is a study that found greater omega-3 consumption associated with lower risk of AMD. Here is a study that found AMD associated with inflammation (too little omega-3 increases inflammation). Here is a study that found no association between vitamin and mineral intake and AMD. Based on this, if 23andme told me I had an increased risk of AMD, I would make sure to optimize my intake of flaxseed oil (or other omega-3 source) using some sort of brain test. I have documented in other posts that brain function is sensitive to omega-3 intake and (probably) most people don’t get enough. Of course, just as it is foolish to smoke (a lot) regardless of whether you have genetic risk of AMD, it is foolish to not optimize one’s omega-3 intake, whether or not you have genetic risk of AMD. In other words: everyone should optimize their omega-3 intake. If the 23andme results cause McCauley to do something wise like this that he would otherwise not have done, they have helped him.

The omega-3 study appeared after the Wired article so I don’t know how McCauley reacted to it. A puzzle about the story is that it isn’t even clear that the gene/AMD associations are true. Consider McCauley’s older relatives: parents, grandparents. Did/do any of them have AMD? If not, it is more plausible that all of them were at 12% risk of the disease than at 50% risk. Suppose all of them had, according to 23andme, the same increased risk as McCauley (at least some of them have the risk-bearing genes). Now it becomes more plausible that something is wrong with the 23andme risk estimate. If some of McCauley’s older relatives do have AMD, it is not clear why the 23andme results would make much difference. He should have already have known he was at increased risk of AMD.

The upshot is that in this particular case, I cannot even rule out Scenario 4 (does harm). All four scenarios strike me as plausible. Based on this article, we are a long way from learning the value of personal genomics.

Previously I used the example of Aaron Blaisdell to make the possibly counter-intuitive point that if you have a genetic disease something is wrong with your environment. Well, I do not have any obvious genetic disease. But I discovered, via self-experimentation, that my environment was terrible — meaning it could be improved in all sorts of ways: stop eating breakfast, drink flaxseed oil, eat butter, look at faces in the morning, take Vitamin D in the morning, and so on, not to mention eat fermented foods (which I figured out via psychology, not self-experimentation). My findings about what is optimal are so different than the way anyone now lives (except people who read this blog) that I believe everyone‘s environment can be vastly improved. If so, the value of discovering you have a genetically elevated risk of this or that is not obvious — you should already be trying to improve your environment. At least that is what my data has taught me. On the other hand, maybe genetic info (even wrong genetic info!) will give you a kick in the pants. Maybe that has happened with McCauley.

 

Variation in Abbott Blood Sugar Test Strips: A Warning

I’ve measured my fasting blood sugar (= blood sugar before breakfast) for about four years. I began out of curiosity but became alarmed when the values approached “pre-diabetic” (> 100 mg/dl, diabetic is 126 mg/dl or so). Eventually I learned that walking an hour/day put them in the 80′s consistently. Perhaps 84 is optimal, who knows.

I have used Abbott test meters and strips. They need so little blood that testing is painless. Recently (January 2012?) Abbott introduced new “butterfly” test strips that “wick” the blood. The meters stayed exactly the same. The new test strips are certainly better. I started to use them. I started using them after a gap (a month?). All of a sudden my scores were about 5 mg/dl better — for example, 84 instead of 89. I assumed this was due to lifestyle changes on my part. I was walking more, I was more muscular, whatever. These were plausible explanations. Surely Abbott had not corrected a huge mistake (given the size of the business, the importance of diabetes, and the need for accurate test strips, to be consistently off by 5 mg/dl would be a huge mistake).

Now I wonder. I recently found some old-style test strips, barely expired (2012/04). I have compared them to the new-style strips (expiration 2013/06). Here are my results:

Morning 1. New: 81, 84. Old: 99, 91, 100.

Morning 2. New: 80. Old: 96, 94, 95.

Morning 3. New: 84. Old: 104, 97, 105.

Morning 4. New: 86. Old: 101, 100, 100.

These results involve three different meters. The old strips come from three separate vials. It is clear that the old strips produce readings much higher (about 15 mg/dl higher) than the new strips.

The old strips are expired but I doubt they got 15 mg/dl worse in 1-2 months. I expect they are accurate when they leave the factory and slowly get worse. Now I have some idea of how much worse (and in what direction). Apparently there is a big increase in bias with little increase in variability. I’ve gone from batch to batch before and never noticed a difference. Only when comparing the new strips with the old has a difference been clear. The earlier comparison, with a 5 mg/dl difference, compared unexpired old strips with the new strips.

I conclude that with the old strips, deterioration with age is worse than I expected and I should pay more attention to test strip age.